Purchase Order 36C24226P0783

<p>Veterans Integrated Service Network 2 issued a purchase order to Covermymeds Pharmacy LLC for $16,331.35 on June 5, 2026, for Pomalyst 3 mg capsules for the Brooklyn VAMC outpatient pharmacy. Performance occurs in Memphis, Tennessee. The order carries a firm fixed price and is due for completion by June 26, 2026. No small business set-aside applied.</p>

The Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a purchase order to CoverMyMeds Pharmacy LLC for the supply of Pomalyst 4mg capsules. This firm fixed-price contract, valued at $16,421.95, was awarded on March 26, 2026, with an ultimate completion date of June 26, 2026. The contract involves no set-aside designation and will be performed in Memphis, Tennessee. Pomalyst (pomalidomide) is a prescription medication used in the treatment of certain blood cancers,...

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to CoverMyMeds Pharmacy LLC for the emergency procurement of Pomalyst 3 mg capsules (NDC 59572-0503-21) with a ceiling value of $16,331.35. The contract was awarded on February 26, 2026, with an ultimate completion date of March 5, 2026, reflecting the urgent nature of this pharmaceutical acquisition. The place of performance is located in Memphis, Tennessee. No set-aside...

Covermymeds Pharmacy LLC was awarded a firm fixed price purchase order by the Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs, for the supply of Pomalyst 4 mg capsules. The contract, awarded on April 17, 2026, carries a ceiling value of $16,421.95 and is scheduled for ultimate completion by July 17, 2026. The pharmaceutical products will be delivered to the place of performance in Memphis, Tennessee. This purchase order represents a...

<p>Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company on May 21, 2026, for Pomalidomide (Pomalyst) 4mg capsules, with a ceiling value of $16,421.95 and an ultimate completion date of May 26, 2026. The call is placed under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. Performance occurs in Memphis, Tennessee. The order is firm fixed price with no set-aside designation.</p>

<p>The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a BPA call to Bristol-Myers Squibb Company on May 29, 2026, for POMALYST 2 MG, 3 MG, and 4 MG with a ceiling value of $149,435.80. The call was issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. Performance occurs in Memphis, Tennessee, with an ultimate completion date of June 4, 2026. Pricing is firm fixed price with no set-aside designation.</p>

The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a BPA call to Bristol-Myers Squibb Company on June 11, 2026, with a ceiling value of $16,767.72. The call is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract, a multiple-award IDIQ with the VA carrying a $12.278 billion ceiling through April 30, 2029. The call procures POMALYST 2 MG, a specialty oncology pharmaceutical. Place of performance is Memphis, Tennessee. The call...

The Defense Logistics Agency issued a $32,160.50 delivery order to AmerisourceBergen Drug Corp on April 1, 2026, for Pomalyst 2 mg capsules (21-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 and running through December 2026), which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is April 22,...

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 24, 2026, for Pomalyst 2 mg capsules (21-count) with a ceiling value of $16,080.25 under firm fixed-price terms.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion by April 14, 2026. No set-aside was used.</p>

The Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company on May 7, 2026, for Pomalyst 3 mg capsules (oncology pharmaceutical) with a ceiling value of $10,887.57. The call is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract with the Department of Veterans Affairs, which carries a $12.278 billion ceiling and extends through April 30, 2029. Place of performance is Memphis, Tennessee. The call completion date is May 13,...